Suppression of endogenous hydrocortisone with dexamethasone.
A newly developed high-pressure liquid chromatographic method was used to study the optimum dosage regimen needed to suppress endogenous hydrocortisone. Nine volunteers were randomly placed in three groups. Each group received 1 mg of dexamethasone at 11 pm (Treatment A), 2 mg of dexamethasone at 11 pm (Treatment B), or 1 mg at 11 pm and an additional 1 mg at 6 am the following day (Treatment C). Analysis of multiple blood samples obtained the day before and the day after drug administration showed suppression in all three groups. Although the duration and extent of this suppression varied, adequate suppression to permit bioavailability studies was observed for Treatments B and C.
D000328:Adult; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003864:Depression, Chemical; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D003907:Dexamethasone; D006854:Hydrocortisone